Vaxcyte to present phase 3 trial data for vaccine candidate
Vaxcyte to present phase 3 trial data for vaccine candidate
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Vaxcyte to present phase 3 trial data for vaccine candidate
Former Anthropic researcher Coxon to testify at New York City AI hearing, Bloomberg News reports
Former Anthropic researcher to testify at NYC Council AI hearing - report
Schneider Electric close to $20 bln deal of U.S. software maker PTC - report
Delfin to tender full 17.6% Monte dei Paschi stake into Intesa’s takeover offer
Alaska LNG shipping savings justifies billions in investment, developer says
France’s Schneider Electric nears $20 billion deal to buy US software group PTC, FT reports
AkzoNobel nears sale of south-east Asian paints unit to Nippon Paint - report
AkzoNobel could sell unit to Nippon Paint for over $1 billion, FT reports
Congress is gone from Washington for the final pre-election recess, and it's time to take stock of what's going on ahead of November.
How Brazil’s election winner could reshape its institutions as vacancies mount
Musk says SpaceX to change name to ’SpaceXSI’
Musk says he will rename SpaceXAI to SpaceXSI
Trump adviser Hassett urges Powell to leave Fed board after renovation report
Woman at center of Cornell rape allegations targeted with threats, lawyer says
Switzy Announces Expansion of SwitzyMan Digital Brand Across Trading, Entrepreneurship and Lifestyle
DealHub AI Named #1 Among 2026 Quote-to-Billing Platforms
Nicaragua announces withdrawal from Central American Parliament
As third-quarter earnings kick off this week, more companies than ever have expressed optimism about their bottom lines.
Crypto firms have spent years building financial products on blockchains. Getting people to use them — and keep using them — is becoming the next challenge.
News text belongs to its source; only the headline and a short summary appear here.